Liquidia Technologies

Liquidia Technologies

Yahoo Finance • 2 days ago

UBS flags 56 stocks where growth and profitability may be underpriced

[Hands holding up columns of bar graph] We Are UBS Global Research has constructed a 56-stock basket of U.S. companies with higher forward growth, stronger cash-flow profitability and improving earnings momentum, arguing that valuations f... Full story

Yahoo Finance • 7 days ago

Liquidia extends losses as Wells Fargo adds to downgrades on legal setback

[The New York Stock Exchange on the Wall street sign] Dmitry Vinogradov Liquidia (LQDA [https://seekingalpha.com/symbol/LQDA]) is heading for its worst weekly decline on Friday after a legal setback in its patent dispute with United Thera... Full story

Yahoo Finance • 8 days ago

Sector Update: Healthcare Stocks Fall Late Afternoon

Healthcare stocks declined late Thursday afternoon, with the NYSE Healthcare Index falling 1% and th PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 8 days ago

Exxon Mobil downgraded, BP upgraded: Wall Street's top analyst calls

Exxon Mobil downgraded, BP upgraded: Wall Street's top analyst calls The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled... Full story

Yahoo Finance • 9 days ago

Stocks making the biggest moves midday: Rogers, United Therapeutics, Moderna, FormFactor & more

Check out the companies making the biggest moves midday: Rogers — The maker of circuit materials surged 10% on better-than-expected earnings guidance. The company sees full-year earnings around $3.80 per share, excluding certain items, abo... Full story

Yahoo Finance • last month

Liquidia Corporation’s (LQDA) Yutrepia Launch Continues to Outpace the Expectations

Summers Value Partners, a boutique investment firm, noted in its Q2 2026 investor update that The Summers Value Fund delivered strong results in the quarter, returning 41.7% net, outperforming the Russell 2000 Index ETF (IWM), which return... Full story

Yahoo Finance • last month

Liquidia to Present Posters at the European Respiratory Society (ERS) 2026 Congress

Liquidia Technologies, Inc. MORRISVILLE, N.C., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respir... Full story

Yahoo Finance • 2 months ago

Will LQDA's Differentiated PAH Approach Drive Growth?

Liquidia Corporation LQDA is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (P... Full story

Yahoo Finance • 2 months ago

Why Liquidia Stock Was Diving This Week

Key Points The shares had risen by 155% year-to-date prior to earnings. Regardless, its one commercialized drug is doing well by any measure.10 stocks we like better than Liquidia › Liquidia(NASDAQ: LQDA) hasn't been the healthiest healt... Full story

Yahoo Finance • 2 months ago

Here are the major earnings before the open Wednesday

Major earnings expected before the bell on Wednesday include: * Nebius Group N.V. (NBIS [https://seekingalpha.com/symbol/NBIS]) * Tencent Holdings Limited (TCEHY [https://seekingalpha.com/symbol/TCEHY]) * Brinker International (EAT... Full story

Yahoo Finance • 2 months ago

3 Top Ranked Stocks Breaking Out Now

Regardless of what is happening in the world, whether geopolitical conflict, a cyclical downturn or the unwinding of an overleveraged hedge fund, a disciplined investment process remains the best tool for making consistent decisions with p... Full story

Yahoo Finance • 2 months ago

Liquidia Corporation to Report Second Quarter 2026 Financial Results on August 12, 2026

MORRISVILLE, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases,... Full story

Yahoo Finance • 3 months ago

Liquidia jumps as judge criticizes United Therapeutics in patent dispute

[Judge Gavel Beside Open Law Book With Turning Pages] jittawit.21/iStock via Getty Images Liquidia Corp. (LQDA [https://seekingalpha.com/symbol/LQDA]) rose 8% after a judge in a long-standing patent dispute with United Therapeutics (UTHR... Full story

Yahoo Finance • 3 months ago

Seeking Alpha’s Quant Spotlight: Highest and lowest rated healthcare stocks ahead of Q2

[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] iQoncept/iStock via Getty Images The Health Care Select Sector SPDR® Fund ETF (XLV [https://seekingalpha.com/symbol/XLV]), which tracks the health ca... Full story

Yahoo Finance • 3 months ago

NVO Stock Up on EC Approval of Wegovy Pill to Treat Obesity

Novo Nordisk NVO received a boost after the European Commission (EC) approved once-daily oral version of Wegovy (semaglutide 25 mg) for the treatment of adults with obesity, with at least one weight-related comorbidity, alongside a reduced... Full story

Yahoo Finance • 3 months ago

Here’s Laughing Water Capital’s Updates on Liquidia Corp. (LQDA)

Laughing Water Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The second quarter was exceptionally good for the portfolio, with Class A investment i... Full story

Yahoo Finance • 3 months ago

Can LQDA's Yutrepia Drive Growth in the Competitive PAH Market?

Liquidia Corporation LQDA is banking on lead drug's Yutrepia's ability to sustain its strong commercial momentum despite intense competition in the pulmonary arterial hypertension (PAH) market. The drug is an inhaled dry-powder version of... Full story

Yahoo Finance • 3 months ago

IHE vs. PJP: Which Pharmaceutical ETF Is the Better Buy for Investors?

The iShares U.S. Pharmaceuticals ETF (NYSEMKT:IHE) offers lower fees and a higher dividend yield, while the Invesco Pharmaceuticals ETF (NYSEMKT:PJP) spreads its holdings more evenly across the sector's biggest players. Investors seeking... Full story

Yahoo Finance • 4 months ago

Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index

Liquidia Technologies, Inc. MORRISVILLE, N.C., June 08, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respira... Full story

Yahoo Finance • 4 months ago

Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

NEW YORK, June 5, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, June 22, 2026, to coincide with the... Full story